Keywords: USA, Obama FY2013 budget, PhRMA, FDA, Medicare, Biosimilars, Patent settlements

PhRMA slams US President’s fiscal year 2013 budget plan

Article | 15 February 2012

Responding to US President Barack Obama’s fiscal year 2013 budget proposals, Pharmaceutical Research and Manufacturers of America (PhRMA) president and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in